Aac Holdings, Inc. (AAC): Michael T. Cartwright , Chairman and CEO of Aac Holdings, Inc. sold 86,481 shares on Jun 8, 2016. The Insider selling transaction was reported by the company on Jun 10, 2016 to the Securities and Exchange Commission. The shares were sold at $21.44 per share for a total value of $1,862,805.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 8, 2016, Jerrod N. Menz (10% owner) sold 59,300 shares at $21.68 per share price.On Jun 3, 2016, Kirk R. Manz (Chief Financial Officer) sold 599 shares at $22.50 per share price.Also, On Jun 3, 2016, Kathryn Sevier Phillips (General Counsel and Secretary) sold 3,500 shares at $21.08 per share price.On May 9, 2016, Michael T. Cartwright (Chairman and CEO) sold 20,602 shares at $21.86 per share price.
Shares of AAC Holdings Inc (AAC) ended Thursday, Jun 9, 2016 session in red amid volatile trading. The shares closed down -0.49 points or -2.27% at $21.09 with 1,36,666 shares getting traded. Post opening the session at $21.42, the shares hit an intraday low of $20.77 and an intraday high of $21.465 and the price vacillated in this range throughout the day. The company has a market cap of $500 M and the number of outstanding shares has been calculated to be 2,37,21,125 shares. The 52-week high of AAC Holdings Inc is $46.6 and the 52-week low is $14.36.
Company has been under the radar of several Street Analysts.AAC Holdings Inc is Upgraded by Mizuho to Buy and the brokerage firm has set the Price Target at $24. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on May 25, 2016.
AAC Holdings Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company operates approximately seven residential substance abuse treatment facilities and one outpatient substance abuse treatment facility. Its substance abuse treatment facilities are located throughout the United States focused on delivering clinical care and treatment solutions across its approximately 560 beds which includes approximately 378 licensed detoxification beds. It has made investments in its treatment facilities. The Company provides care to adults and adolescents struggling with alcohol and/or drug abuse and dependence as well as co-occurring mental health issues. The Company offers various treatment services which include detoxification residential treatment partial hospitalization and intensive outpatient services.